Static Chart Medexus Pharmaceuticals Inc.

Equities

Delayed Toronto S.E. Other stock markets 02:21:17 2024-05-21 pm EDT			5-day change	1st Jan Change
1.6 ^CAD	0.00%		0.00%	-35.22%

Mar. 26	Medexus Pharmaceuticals Announces US Food and Drug Administration Approves It's Supplemental Biologics License Application for IXINITY(R)	CI
Feb. 09	Medexus Pharmaceuticals Maintained at Speculative Buy at Stifel GMP After Fiscal Q3 Miss; Price Target Cut to C$2.85	MT

Duration

Period